Comparison of Postoperative Analgesic Effect of Intrathecal Clonidine and Fentanyl Added to Bupivacaine in Patients Undergoing Cesarean Section
Information source: Qazvin University Of Medical Sciences
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Post Operative Pain
Intervention: distilled water (Drug); Clonidine (Drug); Fentanyl (Drug)
Phase: Phase 1/Phase 2
Status: Completed
Sponsored by: Qazvin University Of Medical Sciences
Summary
Objective :To compare the analgesic effect of intrathecal clonidine and fentanyl as an
additive to bupivacaine in patients undergoing cesarean section .
Methods: Following Ethics Committee approval and informed patients consent, Ninety patients
18-45 yr old ASA physical status I or II, scheduled for cesarean section under spinal
anesthesia, were studied in a prospective, double-blinded, randomized way. The patients were
randomly allocated to one of three groups of 30 each. The clonidine group (groupC) received
bupivacaine 10mg combined with 75microgram clonidine preservative free ,the fentanyl group
(group F) received bupivacaine 10mg combined with25microgram fentanyl and the placebo group
(group P) received bupivacaine 10mg combined with 0. 5ml distilled water intrathecally . Time
to first requirement of analgesic supplement, Sensory block onset time, maximum sensory
level , onset of motor block, duration of blockade, hemodynamics variables, the incidence of
hypotension, ephedrine requirements, bradycardia ,hypoxemia [Saturation of peripheral oxygen
(SpO2)<90], postoperative analgesic requirements and Adverse events, such as sedation,
dizziness , Pruritus and postoperative nausea and vomiting were recorded. Patients were
instructed preoperatively in the use of the verbal rating scale (VRS) from 0 to 10 (0no
pain, 10maximum imaginable pain) for pain assessment. If the VRS exceeded four and the
patient requested a supplement analgesic, diclofenac Na supp 100 mg was to be given for
post-operative pain relief as needed . For breakthrough pain(VRS >4) if time of
administration of diclofenac Na less than 8h,Pethidine 25 mg IV was given.
Clinical Details
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Primary outcome: Time to first requirement of analgesic supplementPostoperative analgesic requirements
Secondary outcome: Sensory block onset time will be assessed by a pinprick testduration of sensory block will be assessed by a pinprick test the onset of motor block will be assessed by the modified Bromage score duration of motor block will be assessed by the modified Bromage score
Eligibility
Minimum age: 18 Years.
Maximum age: 45 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Patients with American Society of Anesthesiologists(ASA) physical status I and II,
undergoing elective cesarean section
Exclusion Criteria:
- Significant coexisting disease such as hepato-renal and cardiovascular disease
- Any contraindication to regional anesthesia such as local infection or bleeding
disorders
- Allergy to ketamine or midazolam
- Long-term opioid use or a history of chronic pain. -
Locations and Contacts
Qazvin university of medical science, Qazvin 34197/59811, Iran, Islamic Republic of
Additional Information
Starting date: August 2011
Last updated: May 16, 2012
|